Nadofaragene Firadenovec Showcases Sustained Responses in BCG-Unresponsive NMIBC
The intravesical gene therapy elicited durable remissions in a high percentage of patients with high-risk, BCG-unresponsive non–muscle invasive bladder cancer.
The intravesical gene therapy elicited durable remissions in a high percentage of patients with high-risk, BCG-unresponsive non–muscle invasive bladder cancer.
Lisa Machtigall, MD, highlights the latest clinical research about Cushing’s disease from ENDO 2023 in this 30 min CE program.
Ozlem Goker-Alpan, MD, Founder and CMO of LDRTC, discusses the importance of newborn screening for lysosomal disorders.
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer…
The FDA has granted accelerated approval to lisocabtagene maraleucel for the treatment of select adult patients with relapsed or refractory follicular lymphoma.
Supported by an independent educational grant from AbbVie Inc. Join Drs Camidge and Dagogo-Jack in Chicago as they discuss the latest information on MET-altered NSCLC.…
Registration is now open
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization University of North Carolina School…
Randomized clinical trials (RCTs) define the efficacy of new cancer treatments and drive changes in clinical practice. Although the role of RCTs in generating knowledge…
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer…